A phase 2 study of durvalumab plus DOS (docetaxel, oxaliplatin, S-1) neoadjuvant chemotherapy followed by surgery and adjuvant durvalumab plus S-1 chemotherapy in patients with resectable locally advanced gastric cancer: An interim efficacy report.

被引:0
|
作者
Kim, Hyung-Don
Ryu, Min-Hee
Park, Young Soo
Lee, Jong Seok
Kang, Yoon-Koo
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Asan Med Ctr, Dept Pathol, Seoul, South Korea
[3] Asan Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
408
引用
收藏
页码:408 / 408
页数:1
相关论文
共 50 条
  • [41] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [42] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Hirohiko Sato
    Mitsuo Shimada
    Nobuhiro Kurita
    Takashi Iwata
    Kozo Yoshikawa
    Jun Higashigima
    Motoya Chikakio
    Hideya Kashihara
    Chie Takasu
    Noriko Matsumoto
    Shozo Eto
    International Journal of Clinical Oncology, 2015, 20 : 543 - 548
  • [43] Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer
    Sato, Hirohiko
    Shimada, Mitsuo
    Kurita, Nobuhiro
    Iwata, Takashi
    Yoshikawa, Kozo
    Higashigima, Jun
    Chikakio, Motoya
    Kashihara, Hideya
    Takasu, Chie
    Matsumoto, Noriko
    Eto, Shozo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 543 - 548
  • [44] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [45] Efficacy of Conversion Surgery Following S-1 plus Cisplatin or Oxaliplatin Chemotherapy for Unresectable Gastric Cancer
    Fukuchi, Minoru
    Mochiki, Erito
    Ishiguro, Toru
    Ogura, Toshiro
    Sobajima, Jun
    Kumagai, Youichi
    Ishibashi, Keiichiro
    Ishida, Hideyuki
    ANTICANCER RESEARCH, 2017, 37 (03) : 1343 - 1347
  • [46] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    Takahari, D.
    Hamaguchi, T.
    Yoshimura, K.
    Katai, H.
    Ito, S.
    Fuse, N.
    Kinoshita, T.
    Yasui, H.
    Terashima, M.
    Goto, M.
    Tanigawa, N.
    Shirao, K.
    Sano, T.
    Sasako, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1423 - 1428
  • [47] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    D. Takahari
    T. Hamaguchi
    K. Yoshimura
    H. Katai
    S. Ito
    N. Fuse
    T. Kinoshita
    H. Yasui
    M. Terashima
    M. Goto
    N. Tanigawa
    K. Shirao
    T. Sano
    M. Sasako
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1423 - 1428
  • [48] S-1 AND OXALIPLATIN REGIMEN NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY FOR RESECTABLE ADVANCED GASTRIC CANCER WITH MULTIPLE LYMPH-NODE METASTASIS
    Udaka, T.
    Nishiyama, T.
    Watanabe, N.
    Endou, I.
    Yoshida, O.
    Asano, H.
    Kubo, M.
    WORLD CANCER RESEARCH JOURNAL, 2022, 9
  • [49] Phase III trial to evaluate the efficacy of neoadjuvant chemotherapy with S-1 plus oxaliplatin followed by D2 gastrectomy with adjuvant S-1 in locally advanced gastric cancer: Japan Clinical Oncology Group study JCOG1509 (NAGISA trial).
    Tokunaga, Masanori
    Mizusawa, Junki
    Machida, Nozomu
    Fukagawa, Takeo
    Katai, Hitoshi
    Nishida, Yasunori
    Yabusaki, Hiroshi
    Ito, Seiji
    Sano, Takeshi
    Sasako, Mitsuru
    Boku, Narikazu
    Yoshikawa, Takaki
    Katayama, Hiroshi
    Haruhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] A phase I/II study of S-1 plus cisplatin alternating with S-1 plus docetaxel in patients with advanced gastric cancer (AGC)
    Hosokawa, A.
    Ogawa, K.
    Kajiura, S.
    Tsukioka, Y.
    Kobayashi, T.
    Horikawa, N.
    Kobayashi, Y.
    Yoshioka, A.
    Sumi, S.
    Sugiyama, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)